Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions.

Labarta, José I; Dimitri, Paul; Keiser, Matthew; Koledova, Ekaterina; Rivera-Romero, Octavio

Labarta, José I; Dimitri, Paul; Keiser, Matthew; Koledova, Ekaterina; Rivera-Romero, Octavio.

Afiliación

Labarta JI; Unit of Endocrinology, Department of Pediatrics, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Dimitri P; Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Keiser M; Department of Paediatric Endocrinology, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.
Koledova E; Ares Trading SA (an affiliate of Merck KGaA), Eysins, Switzerland.
Rivera-Romero O; Global Medical Affairs Cardiometabolic & Endocrinology, Merck Healthcare KGaA, Darmstadt, Germany.

JMIR Hum Factors ; 10: e46893, 2023 Aug 02.

Article en En | MEDLINE | ID: mdl-37531173

Palabras clave

connected health; growth hormone deficiency; mobile phone; participatory health informatics; recombinant human growth hormone; technology acceptance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: JMIR Hum Factors Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google